# Dapsone

NDC: 70771-1980
Generic name: Dapsone
Labeler / Manufacturer: Zydus Lifesciences Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20260227

FDA application: ANDA220103

## Active ingredients

- DAPSONE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70771-1980"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70771-1980
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d6bc112-ba2f-40ab-975d-9cfbc853cd11